VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CICigna Corporation
$282.79$74.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCICash Flow

Cigna Corporation (CI) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash flow generation remains inconsistent, evidenced by an OCF/NI ratio that swung from a negative 17.47 in 2024Q1 to a positive 4.98 in 2025Q4, largely driven by volatile working capital changes.

CI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations8.81B9.6B10.36B11.81B8.66B7.19B10.35B9.48B3.77B4.09B4.03B2.93B2.16B719M2.35B1.49B1.74B745M1.66B1.34B642M718M1.45B2.31B1.38B1.08B1.67B1.82B886M1.83B700M
Operating CF Margin %-3.49%4.19%6.05%4.8%4.13%6.45%6.18%7.75%9.77%10.11%7.74%6.18%2.22%8.07%6.89%8.27%4.05%8.67%7.61%3.88%4.3%7.98%12.27%7.12%5.8%8.56%9.7%5.02%15.58%3.69%
Operating CF Growth %6495.62%-7.35%-12.27%36.47%20.37%-30.52%9.12%151.59%-7.73%1.49%37.27%35.91%200.14%-69.4%57.61%-14.46%133.96%-55.01%23.4%109.03%-10.59%-50.48%-37.18%67.49%27.59%-35.41%-7.98%105.08%-51.72%162.14%-36.59%
Net Income6.29B6.29B3.78B5.37B6.78B5.42B8.49B5.12B2.65B2.23B1.84B2.08B2.09B1.48B1.62B1.26B1.28B1.3B290M1.12B1.16B1.28B1.44B584M-397M971M981M699M1.19B812M1.06B
Depreciation & Amortization2.75B2.77B2.77B3.04B2.94B2.92B2.8B3.65B695M566M610M585M588M597M560M345M292M268M244M194M208M221M230M246M221M244M233M225M318M255M0
Stock-Based Compensation0000000000000000000000000000000
Deferred Taxes482M326M-95M-1.66B-472M-216M-386M-313M-101M242M74M21M-22M197M134M217M188M319M-221M0-23M394M-72M168M-41M205M-69M47M-167M-46M126M
Other Non-Cash Items81M11M2.71B1.58B-1.18B-57M-4.15B-175M81M281M-169M251M-73M-2.49B-34M-117M-83M11M601M-98M-695M-885M-186M1.11B-761M128M-1.7B-15M-1.5B-854M431M
Working Capital Changes-1.14B201M1.19B3.49B584M-879M3.6B1.2B449M765M1.67B-1M-429M938M66M-215M63M-1.16B742M126M-7M-288M40M201M2.36B-459M2.24B861M1.15B1.74B-913M
Change in Receivables-2.33B0-7.85B-2.2B-1.84B-3.5B-1.57B-990M471M-118M909M-890M-758M259M-9M-31M99M49M219M47M162M451M576M248M-100M-33M-453M-99M-159M44M-140M
Change in Inventory0------------------------------
Change in Payables-806M09.89B5.51B3.49B2.04B4.24B1.15B-510M731M125M00000000126M-106M-345M-1.22B-38M2.08B-171M1.65B1.24B856M956M-328M
Cash from Investing-6.24B-4.41B-2.1B-5.17B3.1B-3.61B2.98B-734M-26.38B-1.7B-2.57B-1.74B-1.87B15M-3.86B-1.27B-1.34B-1.49B-2.57B269M1.55B258M1.22B-796M-1.49B-2.01B-902M2.5B871M-1.57B-357M
Capital Expenditures-1.15B-1.21B-1.41B-1.57B-1.29B-1.15B-1.09B-1.05B-528M-471M-461M-510M-473M-527M-408M-422M-300M-307M-257M-262M-136M-61M-38M-107M-303M00-3.45B000
CapEx % of Revenue0.41%0.44%0.57%0.81%0.72%0.66%0.68%0.68%1.09%1.13%1.16%1.35%1.35%1.63%1.4%1.95%1.42%1.67%1.35%1.49%0.82%0.37%0.21%0.57%1.57%--18.42%---
Acquisitions0------------------------------
Investments-------------------------------
Other Investing-5.67B-3.48B-838M-264M-233M-50M-71M-119M-109M-95M50M140M142M553M358M151M-106M-20M-342M875M-40M-19M-24M0-35M-608M-243M3.34B-411M1B-144M
Cash from Financing-3.88B-6.42B-7.65B-4.29B-11.24B-8.21B-8.53B-7.19B23.52B-2.65B-225M-530M-1.58B-930M-228M2.87B274M307M314M-1.04B-2.51B-1.78B-1.53B-1.7B-235M670M-774M-4.21B-1.54B658M-593M
Debt Issued (Net)0------------------------------
Equity Issued (Net)-1.92B-3.42B-6.73B-2.1B-7.22B-7.42B-3.67B-1.76B-274M-2.59B-103M-517M-1.5B-853M-87M509M-137M30M-341M-937M-2.51B-1.27B-612M6M-287M-1.1B-1.62B-2.99B-807M-316M-280M
Dividends Paid-1.62B-1.61B-1.57B-1.45B-1.38B-1.34B-15M-15M0000-11M-11M-11M-11M-11M-11M-14M-11M-12M-13M-100M-185M-185M-190M-200M-238M-243M-245M-242M
Share Repurchases-2.11B-3.62B-7.03B-2.28B-7.61B-7.74B-4.04B-1.99B-342M-2.73B-139M-671M-1.61B-1B-208M-225M-201M0-378M-1.19B-2.77B-1.62B-676M0-355M-1.14B-1.7B-3.03B-833M-335M-292M
Other Financing-705M-726M-411M-469M-79M-112M-328M-237M-423M-468M26M-114M-10M50M98M145M90M142M74M-213M-100M000-36M1.6B1.15B-705M-47M598M93M
Net Change in Cash-1.3B126M594M2.36B428M-4.7B4.83B1.56B883M-213M1.22B548M-1.38B-183M-1.71B3.08B681M-418M-628M578M-317M-810M1.13B-183M-343M-261M-33M246M154M927M-272M
Free Cash Flow7.66B8.39B8.96B10.24B7.36B6.04B9.26B8.44B3.24B3.62B3.56B2.21B1.52B192M1.94B1.07B1.44B438M1.4B1.08B506M657M1.4B2.2B1.07B1.09B1.69B-1.63B627M1.23B700M
FCF Margin %2.76%3.05%3.62%5.24%4.08%3.47%5.77%5.49%6.66%8.65%8.95%5.83%4.36%0.59%6.67%4.94%6.85%2.38%7.32%6.13%3.06%3.94%7.69%11.7%5.56%5.84%8.63%-8.72%3.55%10.45%3.69%
FCF Growth %27.45%-6.34%-12.53%39.11%21.93%-34.78%9.73%160.18%-10.32%1.4%61.53%45.1%692.19%-90.11%81.67%-25.92%229.45%-68.69%29.54%113.44%-22.98%-53%-36.48%104.74%-1.01%-35.55%203.18%-360.45%-49.07%75.86%-36.59%
FCF per Share28.9931.5431.6334.4923.5117.7125.1322.2113.1414.8213.738.475.660.676.713.905.241.595.023.811.501.693.385.222.542.403.47-2.760.981.841.02
FCF Conversion (FCF/Net Income)1.22x1.61x3.02x2.29x1.29x1.34x1.22x1.86x1.43x1.83x2.16x1.40x1.03x0.49x1.45x1.18x1.36x0.57x5.67x1.20x0.56x0.44x1.01x3.65x-3.08x1.15x1.77x1.02x0.69x1.69x0.66x
Interest Paid664M01.34B1.33B1.23B1.25B1.44B1.65B267M240M244M245M259M265M248M185M180M158M140M122M00000000000
Taxes Paid216M0898M1.47B1.85B2.24B1.84B1.78B1.02B1.04B1.06B1.19B1.08B519M655M633M326M220M366M455M00000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Regulatory PBM rebate reform

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Volatility

According to quarterly financial data, the relationship between net income and operating cash flow is highly erratic, with the OCF/NI ratio swinging from a negative 17.47 in 2024Q1 to a positive 4.98 in 2025Q4, indicating significant disconnects between accounting profits and actual cash generation.

The extreme variance in the OCF/NI ratio suggests that reported net income is heavily influenced by non-cash actuarial adjustments and reserve movements rather than core operational cash flow. Investors should monitor these fluctuations as they imply that earnings quality may be lower than headline figures suggest, complicating the assessment of true underlying profitability.

Free Cash Flow Margin Instability

As reported in financial statements, Cigna's free cash flow trajectory is characterized by sharp quarterly swings, ranging from a negative 3.2% margin in 2025Q2 to a peak of 8.0% in 2025Q4, reflecting a lack of consistent cash conversion across the company's diverse service and insurance segments.

The inability to maintain a stable FCF margin suggests that the company's cash flow is highly sensitive to the timing of medical claims payments and working capital cycles. This volatility warrants further investigation into whether the business model can generate reliable cash flow independent of seasonal or accounting-driven timing differences.

Working Capital Swings Drive Cash

Based on reported figures, working capital changes have been the primary driver of cash flow volatility, with a massive $3.5 billion inflow in 2025Q4 contrasting sharply with a $4.1 billion outflow in 2025Q2, highlighting the significant impact of timing on the company's liquidity position.

These large, erratic swings in working capital suggest that Cigna's cash position is heavily dependent on the timing of premium receipts and claim disbursements. Such fluctuations may indicate that the company's operational cash flow is less predictable than the steady nature of its recurring revenue model would otherwise imply.

Aggressive Capital Allocation Amid Uncertainty

As evidenced by recent filings, Cigna has prioritized significant capital deployment through share repurchases, including a $4.0 billion outlay in 2024Q1, even as operating cash flow remains inconsistent, suggesting a management focus on EPS support over maintaining a conservative cash buffer for potential regulatory or operational shocks.

The commitment to share buybacks during periods of volatile cash generation may indicate a management preference for financial engineering to offset organic growth challenges. Investors should monitor whether this capital allocation strategy remains sustainable if regulatory pressures on the PBM segment continue to compress margins and restrict future cash availability.

CI — Frequently Asked Questions

Quick answers to the most common questions about buying CI stock.

How much cash does Cigna Corporation (CI) generate from operations?

Cigna Corporation (CI) generated $9.60B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Cigna Corporation's free cash flow?

Cigna Corporation (CI) generated $8.39B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cigna Corporation's capital expenditure (CapEx)?

Cigna Corporation (CI) spent $1.21B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cigna Corporation distribute cash to shareholders?

In 2025, Cigna Corporation (CI) returned $1.61B to shareholders via cash dividends and spent $3.62B on share repurchases. This shows the company's commitment to returning capital to its equity investors.